ÂÜÀòÂÒÂ×

Peter Windisch serves as the Chief Executive Officer of Anaxomics Biotech S.L., an AI biotech company specializing in In Silico Clinical Trials to enhance drug discovery and development. Previously, Peter held the position of Chief Technology Officer and Managing Director at Excelya, and Vice President Operations & General Partner at PRA Health Sciences. Peter's extensive experience also includes leadership roles at ReSearch Pharmaceutical Services as Vice President for Western Europe and EMEA Business Operations, and as Managing Director at IMEREM GmbH. Additionally, Peter co-founded and served as Managing Director at MED Economy GmbH. Peter Windisch completed education in Nuremberg from 1989 to 1993.